Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Priya Chandra
Single Therapeutic and Supratherapeutic Doses of Sacubitril/Valsartan (LCZ696) Do Not Affect Cardiac Repolarization
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Related publications
Single Therapeutic and Supra‐Therapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial
Clinical Pharmacology and Therapeutics
Pharmacology
LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis and Vasculopathy in a Rat Model of Chronic Kidney Disease
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Potential Markers of Sacubitril-Valsartan Tolerance
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Sacubitril/Valsartan Use for the Hospitalist
American Journal of Hospital Medicine
Sacubitril/Valsartan: Beyond Natriuretic Peptides
Heart
Cardiovascular Medicine
Cardiology
Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients
ESC heart failure
Cardiovascular Medicine
Cardiology
Sacubitril/Valsartan Verbessern Auch Den HbA1c-Wert
MMW Fortschritte der Medizin
Medicine
Bedtime Doses of Prazosin Do Not Affect Daytime Salivary Amylase Markers in PTSD
Heliyon
Multidisciplinary
Sacubitril/Valsartan: Evaluation of Safety and Efficacy as an Antihypertensive Treatment
Drugs in Context
Molecular Medicine
Pharmacology